William B Mattes

Summary

Affiliation: Gene Logic Inc
Country: USA

Publications

  1. ncbi Database development in toxicogenomics: issues and efforts
    William B Mattes
    Pfizer Inc, Groton, Connecticut, USA
    Environ Health Perspect 112:495-505. 2004
  2. ncbi Annotation and cross-indexing of array elements on multiple platforms
    William B Mattes
    Investigative Toxicology, Pfizer Inc, Kalamazoo, Michigan, USA
    Environ Health Perspect 112:506-10. 2004
  3. ncbi Cross-species comparative toxicogenomics as an aid to safety assessment
    William B Mattes
    Gene Logic, Gaithersburg, MD, USA
    Expert Opin Drug Metab Toxicol 2:859-74. 2006
  4. ncbi Effects of an E-cadherin-derived peptide on the gene expression of Caco-2 cells
    Anna Maria Calcagno
    Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, Kansas 66047, USA
    Pharm Res 21:2085-94. 2004
  5. ncbi Modulation of cell adhesion molecules in various epithelial cell lines after treatment with PP2
    Anna Maria Calcagno
    Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, Kansas 66047, USA
    Mol Pharm 2:170-84. 2005
  6. ncbi Microarray probe mapping and annotation in cross-species comparative toxicogenomics
    John N Calley
    Department of Integrative Biology, Eli Lilly and Company, Greenfield, Indiana, USA
    Methods Mol Biol 460:159-83. 2008

Detail Information

Publications6

  1. ncbi Database development in toxicogenomics: issues and efforts
    William B Mattes
    Pfizer Inc, Groton, Connecticut, USA
    Environ Health Perspect 112:495-505. 2004
    ....
  2. ncbi Annotation and cross-indexing of array elements on multiple platforms
    William B Mattes
    Investigative Toxicology, Pfizer Inc, Kalamazoo, Michigan, USA
    Environ Health Perspect 112:506-10. 2004
    ..As a final outcome, a cross-chip identifier is generated that may be used to cross-index array elements. The program is available as a practical extraction and report language (Perl) script that can run under any Perl interpreter...
  3. ncbi Cross-species comparative toxicogenomics as an aid to safety assessment
    William B Mattes
    Gene Logic, Gaithersburg, MD, USA
    Expert Opin Drug Metab Toxicol 2:859-74. 2006
    ..These issues are discussed, along with the current state-of-the-art cross-species comparative toxicogenomics in this review...
  4. ncbi Effects of an E-cadherin-derived peptide on the gene expression of Caco-2 cells
    Anna Maria Calcagno
    Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, Kansas 66047, USA
    Pharm Res 21:2085-94. 2004
    ..The goal of this study was to determine the effects of exposure to an HAV peptide (Ac-SHAVSS-NH2) on the protein and gene expression in Caco-2 cells, a model for the intestinal mucosa...
  5. ncbi Modulation of cell adhesion molecules in various epithelial cell lines after treatment with PP2
    Anna Maria Calcagno
    Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, Kansas 66047, USA
    Mol Pharm 2:170-84. 2005
    ..Overall, our data suggest that E-cadherin is positively regulated by inhibition of Src tyrosine kinases at the functional and protein expression levels within these epithelial cell lines...
  6. ncbi Microarray probe mapping and annotation in cross-species comparative toxicogenomics
    John N Calley
    Department of Integrative Biology, Eli Lilly and Company, Greenfield, Indiana, USA
    Methods Mol Biol 460:159-83. 2008
    ..The results of this method are given for an experiment comparing the transcriptional response of canine liver to phenobarbital with that of rat liver...